Comparison

Carfilzomib (PR-171)

Item no. DCC-DC1002-100mg
Manufacturer DCChemicals
CASRN 868540-17-4
Amount 100 mg
Quantity options 100 mg 10 mM x 1 mL in DMSO 1 g 250 mg
Category
Type Inhibitors
Specific against other
Purity >99.5%
Smiles CC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC3=CC=CC=C3)NC(=O)CN4CCOCC4
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias PR171,PR 171
Similar products 868540-17-4
Available
Manufacturer - Applications
Carfilzomib is an irreversible proteasome inhibitor with an IC50 of 5 nM in ANBL-6 and RPMI 8226 cells, showed potent activity against COVID-19(SARS-COV-2).
Storage Conditions
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight
719, 91
Note
For research only, not for human use!
Chemical name
L-Phenylalaninamide, (alphaS)-alpha-[[2-(4-morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close